Alan Saghatelian
12Patents
3h-index
19Co-inventors
53Inventor score
Filing activity: Jun 1, 2005 → Feb 12, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9243038B2 | Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof | Human Necessities | 34 | Active |
| US9610322B2 | Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof | Human Necessities | 30 | Active |
| US7348437B2 | Proteomic analysis | Physics | 4 | Expired |
| US9738697B2 | Alpha/beta-polypeptide analogs of glucagon-like peptide-1 | Human Necessities | 2 | Active |
| US10604473B2 | Lipids that increase insulin sensitivity and methods of using the same | Physics | 2 | Active |
| US8940497B2 | Enzyme regulating ether lipid signaling pathways | Physics | 2 | Active |
| US10189884B2 | Thioamide-modified peptides and uses thereof | Human Necessities | 1 | Active |
| US10947290B2 | Method of stabilizing a bioactive peptide against protease hydrolysis | Human Necessities | 0 | Active |
| US11174216B2 | Lipids that increase insulin sensitivity and methods of using the same | Physics | 0 | Active |
| US11013711B2 | Fatty acid esters of hydroxy fatty acids (FAHFAs) for use in the treatment of type 1 diabetes | Human Necessities | 0 | Active |
| US10723779B2 | Alpha/beta-polypeptide analogs of glucagon-like peptide 1 | Human Necessities | 0 | Active |
| US11891425B2 | Thioamide-modified peptides and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.